L. Sloper

Transforming Growth Factor-&bgr; and Inflammation in Vascular (Type IV) Ehlers–Danlos Syndrome

N. McDonnell, D. Shilane, J. V. Van Eyk, 2014, Circulation. Cardiovascular genetics.

Abstract 5095: The Role of Circulating Transforming Growth Factor-{beta} in Vascular Ehlers-Danlos Syndrome: Implications for Drug Therapy

H. Dietz, N. McDonnell, O. Carlson, 2009 .

Treatment of Erdheim-Chester disease with cladribine: a rational approach

P. Tighe, R. Powell, A. Haynes, 2004, British Journal of Ophthalmology.

Clinical and biochemical profiles suggest fibromuscular dysplasia is a systemic disease with altered TGF- (cid:2) expression and connective tissue features

D. Milewicz, H. Dietz, S. Ganesh, 2014 .

Clinical and biochemical profiles suggest fibromuscular dysplasia is a systemic disease with altered TGF‐β expression and connective tissue features

D. Milewicz, H. Dietz, S. Ganesh, 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Clinical and biochemical profiles suggest fibromuscular dysplasia is a systemic disease with altered TGF‐β expression and connective tissue features

D. Milewicz, H. Dietz, S. Ganesh, 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.